Switch to:
More From Other Websites
Is BioDelivery Sciences (BDSI) a Great Growth Stock? Jan 17 2017
MonoSol Rx Files Patent Infringement Suit against BioDelivery Sciences International (BDSI) Jan 13 2017
BIODELIVERY SCIENCES INTERNATIONAL INC Files SEC form 8-K, Other Events, Financial Statements and... Jan 09 2017
BioDelivery Sciences Closes Transaction to Reacquire License to BELBUCA® from Endo Pharmaceuticals Jan 09 2017
Is the Options Market Predicting a Spike in BioDelivery (BDSI) Stock? Jan 04 2017
Endo International Is Top 'Dog of the S&P 500' Dec 30 2016
BioDelivery Sciences Announces the Hiring of Peter Ginsberg as Vice President of Business... Dec 14 2016
BIODELIVERY SCIENCES INTERNATIONAL INC Files SEC form 8-K, Entry into a Material Definitive... Dec 13 2016
BioDelivery Sciences Announces Clonidine Topical Gel for Painful Diabetic Neuropathy Phase 2b Trial... Dec 13 2016
BioDelivery Sciences International, Inc. (BDSI): How It Stacks Up Against Its Peers Dec 12 2016
Endo (ENDP) Inks Deal to Return Belbuca Rights to BioDelivery Dec 09 2016
After Endo, global plans for BDSI’s Belbuca? Dec 09 2016
BioDelivery Reacquires Rights for Opioid Painkiller Dec 08 2016
ETFs with exposure to BioDelivery Sciences International, Inc. : December 8, 2016 Dec 08 2016
Endo Sells Back Its Rights to Opioid Drug and Moves to Restructure Dec 08 2016
[$$] Endo Sells Back Rights for Opioid Painkiller Dec 08 2016
BioDelivery Sciences Reacquires License to BELBUCA™ from Endo Pharmaceuticals Dec 08 2016
BioDelivery Sciences: Can Bunvail and Belbuca's Sales Improve? Nov 28 2016
BioDelivery Sciences to Present at the 28th Annual Piper Jaffray Healthcare Conference Nov 23 2016
BIODELIVERY SCIENCES INTERNATIONAL INC Financials Nov 17 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK